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Abstract. An acetone extract of Curcuma xanthorrhiza rhizomes and the n-
hexane and chloroform fractions obtained from it were tested on eight 
pathogenic bacteria. The results showed that the acetone extract and the n-
hexane fraction exhibited significant activities against Bacillus subtilis, 
Pseudomonas aeruginosa, and Staphylococcus aureus, and weak activities 
against Shigella dysenteriae and Vibrio cholerae. They were inactive against 
Escherichia coli, Enterobacter aerogenes and Salmonella thypi, while the 
chloroform fraction was devoid of activities. NMR analysis disclosed the 
presence of α-curcumene, xanthorrhizol and an unknown monoterpene in the n-
hexane fraction. In the chloroform fraction, curcumin was found to be the main 
compound, together with xanthorrhizol as a minor compound. These results 
suggest that the antibacterial potency of acetone extract of C. xanthorrhiza is 
contained in the n-hexane fraction, in which the active constituents are terpenoid 
compounds. This is the first report of the use of NMR analysis for compound 
identification contained in an extract or fractions of C. xanthorrhiza. 
Keywords: α-curcumene; antibacterial; Curcuma xanthorrhiza; curcumin; 
xanthorrhizol; NMR analysis; TOCSY-1D. 
1 Introduction 
Although the main sources of antibiotics are bacteria and fungi, recently there 
has been interest to look for new bioactive compounds from plants that are 
capable to partly or completely suppress microbial infections [1]. This approach 
represents an attractive strategy to control the spread of microbial drug 
resistance and it could maintain the use of existing antibiotics that are often 
cheaper and less toxic than new candidate antimicrobials [2]. Curcuma 
xanthorrhiza Roxb. is one of the herbs that are popular in Indonesian jamus [3]. 
The rhizomes of this plant have been known to contain terpenoid and 
curcuminoid compounds [4-10]. Beneficial properties of curcuminoids, such as 
antioxidant, anti-imflammatory, antitumor, and anticancer effects, have been 
investigated by many researchers for a long time [11-13]. Recently, interest in 
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terpenoid extract and its major constituent, xanthorrhizol, as antibacterial and 
antifungal agents has attracted some reseachers [14-18]. These studies were 
motivated by the fact that synthetic antibiotics, apart from their broad and 
strong antimicrobial properties, are believed to have long-term side effects. In 
addition, pathogenic microorganisms are constantly developing resistance to 
these drugs [19]. As an initial study toward finding new antibacterial 
compounds from Indonesian plants, the present study reports antibacterial 
properties of an acetone extract and fractions obtained from the rhizomes of C. 
xanthorrhiza against eight bacteria, as well as the analysis of their constituents 
using the NMR method. This the first report of the use of NMR analysis, 
particularly using TOCSY1D (Total Correlation Spectroscopy One 
Dimensional) experiments, for identification of the compounds contained in an 
extract or fractions obtained from rhizomes of C. xanthorrhiza.  
Table 1    MIC and MBC values of Cx-TA (acetone extract), Cx-H (n-hexane 
fraction) and Cx-C (chloroform fraction) against eight pathogenic bacteria.  
  Cx-TA Cx-H Cx-C Amox Chloram 
Bacillus subtilis MIC 31.2 62.5 >1000 31.2 3.9 
(gram +) MB
C 
62.5 62.5 >1000 62.5 3.9 
Staphylococcus aureus MIC 62.5 62.5 >1000 3.9 3.9 
(gram +) MB
C 
62.5 62.5 >1000 3.9 7.8 
Escherichia coli MIC >1000 >1000 1000 31.2 3.9 
(gram –) MB
C 
>1000 >1000 1000 62.5 3.9 
Enterobacter 
aerogenes 
MIC >1000 500 1000 125 15.6 
(gram –) MB
C 
>1000 500 1000 125 31.2 
Pseudomonas 
aeruginosa 
MIC 7.8 7.8 >1000 62.5 31.2 
(gram –) MB
C 
15.6 15.6 >1000 62.5 31.2 
Shigella dysentriae   MIC 250 250 >1000 15.6 3.9 
(gram –) MB
C 
250 250 >1000 15.6 7.8 
Salmonella thypi MIC >1000 >1000 >1000 3.9 3.9 
(gram –) MB
C 
>1000 >1000 >1000 3.9 7.8 
Vibrio cholereae MIC 500 250 500 62.5 31.2 
(gram –) MB
C 
500 500 500 125 31.2 
MIC and MBC values are in g/mL; Amox = amoxicillin; Cloram = chloramphenicol. 
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2 Results and Discussion 
Extraction of dried powder of C. xanthorrhiza with acetone resulted a dark 
yellow of gummy material. Liquid-liquid fractionation of the acetone extract 
into n-hexane, CHCl3, and EtOAc gave a viscous liquid of n-hexane, CHCl3, 
and EtOAc fractions. The combined weight of the first two fractions showed 
that practically most of the mass of the extract was soluble in these fractions. 
Antibacterial activities of the total acetone extract (Cx-TA), n-hexane (Cx-H), 
and CHCl3 (Cx-C) fractions are presented in Table 1 as MIC (minimum 
inhibitory concentration) and MBC (minimum bactericidal concentration) 
values. As shown in the table, except for S. aureus and S. thypi, all the tested 
bacteria were resistant to amoxicillin, while E. aerogenes, P. aeruginosa, and V. 
cholerae were not susceptible to chloramphenicol. Treatment with Cx-TA and 
Cx-H showed that they strongly inhibited the growth of P. aeruginosa at a 
concentration much lower than amoxicillin and chloramphenicol (MICs 7.8, 
7.8, 62.5, and 31.2 g/mL, respectively). The Cx-TA and Cx-H also exhibited 
potent bactericidal effects on this microorganism (both have an MBC value of 
15.6 g/mL). From the MIC and MBC values, Cx-TA and Cx-H showed 
moderate antibacterial properties against B. subtilis and S. aureus and were 
inactive against the remaining tested bacteria. Meanwhile, the Cx-C fraction 
showed no activity against all tested bacteria. 
The 
1
H NMR data of Cx-TA, Cx-H, and Cx-C are presented in Figure 1. 
Analysis of these spectra showed that α-curcumene (1) and xanthorrhizol (2) 
were the major constituents in the Cx-H, with a mole ratio of almost 1:1, while 
no curcumin was detected. The aromatic proton signals of compounds 1 and 2 
were easily identified from their multiplicities, while identification of the 
aliphatic proton signals was aided by the TOCSY-1D spectra, as shown in 
Figure 2. Through a detailed analysis of the HSQC and HMBC spectra of Cx-H 
(data not shown), the 
1
H and 
13
C NMR parameters of compounds 1 and 2 could 
be determined (Table 2), thus confirming the identity of these compounds as 
xanthorrizol (2) and α-curcumene (1), respectively. In addition to these 
compounds, the Cx-H also contained an unknown terpenoid compound, 
possibly a monoterpene. Different to the Cx-H fraction, the Cx-C fraction 
contained curcumin (3) as its main constituent (NMR parameters data not 
shown). In this fraction, xanthorrhizol (2) was also found, with a 3:2 mole ratio 
of about 2.3:1. This is the first study to analyze the extract and fractions using 
extensive 1-D and 2-D NMR methods, including TOCSY1D experiments. The 
presence of compound 2 in the Cx-H is interesting because an essential oil 
obtained from the rhizomes of this plant collected from India showed an 
absence of this compound [14], while a similar oil from Indonesia contained 
compound 2 as the major constituent [20]. 
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Figure 1 1H NMR spectra of the acetone extract (Cx-TA) (A); n-hexane (Cx-H) 
(B) and chloroform (Cx-C) (C) fractions of C. xanthorrhiza in CDCl3. a, b, and c 
are signals due to α-curcumene (1), xanthorrhizol (2), and curcumin (3), 
respectively. 
Biological properties of the extracts and essential oils from C. xanthorrhiza 
have been studied by many researchers. They include hepatoprotective and 
antinocetiptive activities [21,22], antihypercholesterolemic and cancer 
chemoproptective effects [23,24], and antimicrobial properties [14,25,26]. 
However, in this study the antibacterial activities of an extract and fractions of 
C. xanthorrhiza against eight pathogenic bacteria were investigated for the first 
time. The results revealed that only the total acetone extract (Cx-TA) and the n-
hexane fraction (Cx-H) showed significant antibacterial activities against P. 
aeruginosa and moderate activities against B. subtilis and S. aureus. Weak or no 
activity was observed when tested to S. dysentriae, V. cholerae, E. coli, E. 
aerogenes, and S. thypi. On the other hand, the chloroform fraction (Cx-C) did 
not exhibit any activity against the tested bacteria, suggesting that the active 
constituent(s) of the extract is mainly contained in the Cx-H. From NMR 
analysis of the Cx-H, the active constituent(s) could be either α-curcumene (1), 
xanthorrhizol (2), or an unidentified  terpenoid  compound,   or   a   combination   
of   these   compounds.  
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Figure 2 The 1H TOCSY-1D spectra of the n-hexane fraction showing proton 
signals for α-curcumene (1), xanthorrhizol (2), and an unidentified monoterpene. 
To our knowledge the only biological property reported for compound 1 was 
antitumor activity against Sarcoma 180 Ascities in mice [27]. Its antitumor 
activity was higher than that of compound 2. However, compound 2 has been 
studied for a number of biological targets, notably for its antimicrobial [14-18] 
and anticancer [28-36] properties. In conclusion, this study has shown that the 
antibacterial capacity of C. xanthorrhiza is contained in the n-hexane fraction. 
By using an extensive 1-D and 2-D NMR analysis, the major components of 
this fraction could be identified. 
3 Experimental Procedure 
3.1 Plant Material 
Rhizomes of C. xanthorrhiza were collected from Surakarta, Central Java, 
Indonesia, on March 2010, and were identified by staff of Herbarium 
Bandungense, School of Biological Sciences and Technology, Institut 
Teknologi Bandung. 
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3.2 Extraction and Fractionation 
Dried powder of C. xanthorrhiza (100 g) was macerated with acetone (3 x 24 
hours) to give a dark yellow acetone extract (7.3 g) after evaporating the solvent 
under reduced pressure. The acetone extract (Cx-TA) was partitioned into 
MeOH-n-hexane (1:1) to give n-hexane and MeOH fractions. The MeOH 
fraction was further partitioned into water-CHCl3 to give CHCl3 and aqueous-
MeOH fractions. The aqueous-MeOH layer was extracted into an EtOAc 
fraction. The n-hexane, CHCl3, and EtOAc fractions were evaporated under 
reduced pressure to get Cx-H (5.5 g), Cx-C (1.2 g), and Cx-E (105 mg) 
fractions, respectively.  
Table 2 1H (500 MHz) and 13C (125 MHz) NMR data of α-curcumene (1) and 
xanthorrhizol (2) in CDCl3 
No C 
α-Curcumen (1)  Xanthorrhizol (2) 
H  (mult., J in Hz) C  H (mult., J in Hz) C 
1 7.08 (d, 8.3) 126.8  6.23 (d, 1.5) 113.5 
2 7.11 (d, 8.3) 128.9  - 153.8 
3 - 135.0  - 121.0 
4 7.11 (d, 8.3) 128.9  7.03 (d, 7.6) 130.6 
5 7.08 (d, 8.3) 126.8  6.67 (dd, 7.6, 1.5) 119.1 
6 - 144.6  - 147.0 
7 2.67 (sext., 7.0) 39.0  2.61 (sext., 7.0) 39.0 
8 1.68-1.54 (m) 38.4  1.66-1.50 (m) 38.3 
9 1.85-1.95 (m) 26.0  1.85-1.95 (m) 26.1 
10 5.11 (tm, 7.0) 124.8  5.10 (tm, 7.0) 124.5 
11 - 131.0  - 131.3 
12 1.69 (brs) 25.7  1.69 (brs) 25.6 
13 1.60 (brs) 17.6  1.55 (brs) 17.6 
14 1.23 (d, 7.0) 22.4  1.20 (d, 7.0) 22.3 
15 2.33 (s) 20.9  2.24 (s) 15.4 
3.3 NMR Analysis 
1
H, 
13
C, TOCSY-1D, HSQC-DEPT, and HMBC measurements of the acetone 
extract, n-hexane-, and CHCl3-fractions were carried out in CDCl3 with an 
Agilent DD2 spectrometer operating at 500 (
1
H) and 125 (
13
C) MHz, using the 
standard pulses of the spectrometer. 
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4 Antibacterial Evaluation [37] 
The eight strains of bacteria used in this study include two gram-positive 
bacteria (Bacillus subtilis and Staphylococcus aureus) and six gram-negative 
bacteria (Escherichia coli, Enterococcus aerogenes, Pseudomonas aeruginosa, 
Salmonella typhi, Shigella dysenteriae and Vibrio cholerae). These bacterial 
strains were isolated from clinical samples and were obtained from the 
Microbiology Laboratory, Health Polytechnique, Cimahi, Indonesia. The 
bacterial isolate to be tested was inoculated onto a Mueller Hinton Agar (MHA) 
plate and then incubated for 24 hours at 37°C. The bacteria colonies from the 
fresh agar plate were transferred into a sterile capped glass tube containing a 
sterile broth or saline solution (NaCl 0.9% b/v) using a sterile loop or cotton 
swab and mixed well. The suspension was adjusted to achieve a turbidity 
equivalent to a 0.5 McFarland turbidity standard. This resulted in a suspension 
containing approximately 1 x 10
8
 CFU/mL.  
4.1 Determination of Minimum Inhibitory Concentration [37] 
The minimum inhibitory concentration (MIC) is defined as the lowest 
concentration at which no visible bacterial growth is observed. Determination of 
the MIC was executed using broth microdilution according to the method 
suggested by the Clinical and Laboratory Standards Institute (CSLI) [37]. The 
samples were dissolved in dimethyl sulfoxide (DMSO). The samples were 
prepared to achieve 250 µg/mL in the first well. Two-fold dilution of samples 
was performed in a 96-wells microplate over a range of 1.95 to 250 µg/mL. 
This was achieved by filling all wells with 200 µL of Mueller Hinton Broth 
(MHB) medium. Then 200 µL of sample (500 µg/mL) was transferred into the 
first well. Two-fold serial dilution was performed by transferring 200 µL of the 
mixture from the first well into the next consecutive well until the end of the 
row. At the last well, 200 µL of the mixture was discharged so that the total 
volume solution in each well was 200 µL. Then 10 µL bacterial suspension was 
transferred into all wells. The microplate was incubated for 24 hours at 37°C. 
Bacterial growth was determined using a universal microplate reader. For all 
samples, positive and negative controls were performed in duplicate. The 
positive controls used in this assay were chloramphenicol and amoxycillin. 
4.2 Determination of Minimum Bactericidal Concentration [37] 
The minimum bactericidal concentration (MBC) is defined as the lowest 
concentration at which colonies fail to grow after being incubated. In order to 
determine the MBC, an aliquot was removed from the wells that showed no 
bacterial growth and streaked onto an MHA plate and incubated under the same 
conditions (24 hours at 37°C).  
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